Pembrolizumab Provides First-Ever Overall Survival Improvement in Kidney Cancer
Pembrolizumab (Keytruda) treatment after surgery helped people with clear-cell renal cell carcinoma live longer in a large trial—a first for this cancer
نظر دهید